Suppr超能文献

弗林蛋白酶是肝细胞中血管生成素样蛋白 3 和内皮脂肪酶的主要体内转化酶。

Furin is the primary in vivo convertase of angiopoietin-like 3 and endothelial lipase in hepatocytes.

机构信息

From the Laboratories of Biochemical Neuroendocrinology and.

出版信息

J Biol Chem. 2013 Sep 13;288(37):26410-8. doi: 10.1074/jbc.M113.501304. Epub 2013 Aug 5.

Abstract

The proprotein convertases (PCs) furin, PC5/6, and PACE4 exhibit unique and/or complementary functions. Their knock-out (KO) in mice resulted in strong and specific phenotypes demonstrating that, in vivo, these PCs are unique and essential during development. However, they also exhibit redundant functions. Liver angiopoietin-like 3 (ANGPTL3) inhibits lipolysis by binding to lipoprotein lipases. It is found in the plasma as full length and truncated forms. The latter is more active and generated by cleavage at a furin-like site. Endothelial lipase (EL) binds heparin sulfate proteoglycans on cell surfaces and catalyzes the hydrolysis of HDL phospholipids. EL activity is regulated by two endogenous inhibitors, ANGPTL3 and ANGPTL4, and by PCs that inactivate EL through cleavage releasing the N-terminal catalytic and C-terminal lipid-binding domains. Herein, because furin and PC5/6 complete KOs are lethal, we used mice lacking furin or PC5/6 specifically in hepatocytes (hKO) or mice completely lacking PACE4. In primary hepatocytes, ANGPTL3 was processed into a shorter form of ANGPTL3 intracellularly by furin only, and extracellularly mainly by PACE4. In vivo, the absence of furin in hepatocytes reduced by ∼50% the circulating levels of cleaved ANGPTL3, while the lack of PACE4 had only a minor effect. Analysis of the EL processing in primary hepatocytes and in vivo revealed that it is mostly cleaved by furin. However, the lack of furin or PC5/6 in hepatocytes and complete PACE4 KO did not appreciably modify plasma HDL levels or EL activity. Thus, inhibition of furin in liver would not be expected to modify the plasma lipid profiles.

摘要

蛋白转化酶(PCs)furin、PC5/6 和 PACE4 具有独特和/或互补的功能。它们在小鼠中的敲除(KO)导致了强烈和特异的表型,表明在体内,这些 PCs 在发育过程中是独特和必需的。然而,它们也表现出冗余的功能。肝血管生成素样 3(ANGPTL3)通过与脂蛋白脂肪酶结合来抑制脂肪分解。它以全长和截断形式存在于血浆中。后者更活跃,是通过在类 furin 位点切割产生的。内皮脂肪酶(EL)结合细胞表面的肝素硫酸蛋白聚糖,并催化 HDL 磷脂的水解。EL 活性受两种内源性抑制剂(ANGPTL3 和 ANGPTL4)和 PCs 的调节,后者通过切割释放 N 端催化和 C 端脂质结合结构域使 EL 失活。在此,因为 furin 和 PC5/6 完全 KO 是致命的,所以我们使用肝细胞中特异性缺乏 furin 或 PC5/6(hKO)或完全缺乏 PACE4 的小鼠。在原代肝细胞中,ANGPTL3 仅被 furin 在内质网中加工成较短形式的 ANGPTL3,主要在外质网中被 PACE4 加工。在体内,肝细胞中 furin 的缺失使循环中 cleaved ANGPTL3 的水平降低了约 50%,而缺乏 PACE4 仅有轻微影响。对原代肝细胞和体内的 EL 加工分析表明,它主要被 furin 切割。然而,肝细胞中缺乏 furin 或 PC5/6 和完全缺乏 PACE4 并没有明显改变血浆 HDL 水平或 EL 活性。因此,肝脏中 furin 的抑制预计不会改变血浆脂质谱。

相似文献

5
Analysis of the Contribution of Proprotein Convertases to the Processing of FGF23.分析脯氨酰肽酶原转化酶对 FGF23 加工的贡献。
Front Endocrinol (Lausanne). 2021 Jun 4;12:690681. doi: 10.3389/fendo.2021.690681. eCollection 2021.

引用本文的文献

2
Functional Roles of Furin in Cardio-Cerebrovascular Diseases.弗林蛋白酶在心血管疾病中的功能作用
ACS Pharmacol Transl Sci. 2024 Feb 7;7(3):570-585. doi: 10.1021/acsptsci.3c00325. eCollection 2024 Mar 8.
4
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.ANGPTL3 作为高血脂和动脉粥样硬化的药物靶点。
Curr Atheroscler Rep. 2022 Dec;24(12):959-967. doi: 10.1007/s11883-022-01071-1. Epub 2022 Nov 11.
6
Angiopoietin-like 3: An important protein in regulating lipoprotein levels.血管生成素样蛋白 3:调节脂蛋白水平的重要蛋白。
Best Pract Res Clin Endocrinol Metab. 2023 May;37(3):101688. doi: 10.1016/j.beem.2022.101688. Epub 2022 Aug 12.
10
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.ANGPTL3、ANGPTL4 和 ANGPTL8 对脂蛋白代谢的调节。
Am J Physiol Endocrinol Metab. 2021 Oct 1;321(4):E493-E508. doi: 10.1152/ajpendo.00195.2021. Epub 2021 Aug 2.

本文引用的文献

3
Atypical angiopoietin-like protein that regulates ANGPTL3.一种调节 ANGPTL3 的非典型血管生成素样蛋白。
Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19751-6. doi: 10.1073/pnas.1217552109. Epub 2012 Nov 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验